Through the generosity of Novartis AG limited funds are available to support students studying with the School of Chemistry who find themselves experiencing financial hardship in the course of their studies.
Applications will be assessed through the Dean of Students’ Office using the same application processes as for other financial assistance e.g. the Access to Learning/UEA Hardship Funds.
For more information on how to apply please contact the Dean of Students Office. Note that application for Novartis funds held by the School should be distinguished by writing Novartis and the name of the School at the top of the application form.
Novartis UK is the UK affiliate of Swiss based Novartis AG – one of the largest pharmaceutical companies in the world. This pioneering and innovative company came about through the merger, in 1996, of two key Swiss pharmaceutical organisations, Ciba Geigy and Sandoz. Novartis employs nearly 100,000 people worldwide and has a presence in over 140 countries.
For more information on how to apply please contact the Dean of Students Office. Note that application for Novartis funds held by the School should be distinguished by writing Novartis and the name of the School at the top of the application form.
Novartis UK is the UK affiliate of Swiss based Novartis AG – one of the largest pharmaceutical companies in the world. This pioneering and innovative company came about through the merger, in 1996, of two key Swiss pharmaceutical organisations, Ciba Geigy and Sandoz. Novartis employs nearly 100,000 people worldwide and has a presence in over 140 countries.
